Brimonidine Tartrate eent and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Brimonidine Tartrate eent and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine ophthalmic
Brand name: Alphagan P, Lumify, Alphagan
Synonyms: Brimonidine ophthalmic, Brimonidine (Ophthalmic)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine Tartrate eent-Insulin degludec
- Brimonidine Tartrate eent-Insulin Degludec (U-100) Prefilled Pens
- Brimonidine Tartrate eent-Insulin Degludec (U-100) Vials
- Brimonidine Tartrate eent-Insulin Degludec (U-200) Prefilled Pens
- Brimonidine Tartrate eent-Insulin degludec and liraglutide
- Brimonidine Tartrate eent-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Brimonidine Tartrate topical
- Insulin aspart, recombinant Subcutaneous-Brimonidine topical
- Insulin aspart, recombinant Subcutaneous-Brimonidine Topical application
- Insulin aspart, recombinant Subcutaneous-Brintellix
- Insulin aspart, recombinant Subcutaneous-Brinzolamide
- Insulin aspart, recombinant Subcutaneous-Brinzolamide and Brimonidine